Doxorubicin (DOX) mediated cardiomyopathy is a major challenge in cancer chemotherapy. Redoxcycling of doxorubicin by flavoenzymes makes the heart more vulnerable to oxidative stress leading to cardiac dysfunction. The present study evaluates the role of neferine, a bisbenzylisoquinoline alkaloid, in curbing the molecular consequences of DOX-exposure in H9c2 cardiomyoblasts. Neferine pre-treatment increased cell viability upon DOX-exposure. DOX activates NADPH oxidase subunits, (p22phox, p47phox, gp91phox) as the primary event followed by peak in [Ca 2+ ]i accumulation by 2 h, ROS by 3 h and activated ERK1/2 and p38 MAPKinases, time dependently along with the activation and translocation of NFκB and up-regulated COX2 and TNF-α expressions. Neferine pre-treatment modulated NADPH oxidase/ROS system, inhibited MAPKinases and NFκB activation, reduced sub G1 cell population and concomitantly increased cyclin D1 expression reducing DOX-mediated apoptosis. The study demonstrates for the first time, the molecular sequential events behind DOX toxicity and the mechanism of protection offered by neferine with specific relevance to NADPH oxidase system, MAPKinases, inflammation and apoptosis in H9c2 cells. Our data suggests the use of neferine as a new approach in pharmacological interventions against cardiovascular disorders as secondary complications.
with neferine alone (between 1 and 5 µM) for 24 h offered maintenance in cell viability similar to control group. Treatment with 7.5, 10 and 15 µM neferine alone showed significant proliferative effect compared to control (Fig. 1B) . Pre-treatment with 7.5, 10 and 15 µM neferine followed by DOX-treatment for 24 h offered significant increase in cell viability (78%) at 10 µM neferine pre-treatment compared to 7.5 (68% cell viability) and 15 µM (72% cell viability) neferine pre-treatment (Fig. 1C ). Based on these results, 10 µM neferine with better protective effect was chosen for further studies.
Neferine down-regulates DOX-induced gp91phox (NOX2), p22phox and p47phox expression in H9c2 cells. NADPH oxidase system comprise of defined subunits as membrane bound and cytosolic components. NOX2, p22phox and p47phox are the important subunits in the NADPH oxidase system responsible for the stability and activity of the complex. Hence expression pattern of these subunits was analyzed in a time-course study (0 h, 0.5, 1 h, 3 h, 6 h and 12 h). DOX-treatment in the H9c2 cells markedly induced the expression of NOX2, p22phox, and p47phox in a time dependent manner. We found that protein expression of p22phox, p47phox and gp91phox starts after immediate exposure of DOX from 1 h (Fig. 1D ). From these results, it was apparent that DOX-induced NOX system was the primary event in DOX-induced cardiotoxicity. H9c2 cells pre-treated with neferine (10 µM) for 24 h followed by DOX (1 µM) for 24 h revealed a significant suppression in the expression of these subunits (Fig. 1E,F) .
Neferine inhibited the ROS hypergeneration by DOX in H9c2 cells. ROS plays a vital role in devel-
oping cardiac dysfunction under various pathological conditions. Since, DOX-potentiated the NADPH oxidase system (a major source for cellular ROS generation), we measured the ROS generation in H9c2 cells in a time course experiment (0 h, 0.5 h, 1 h, 2 h, 3 h, 4 h, 5 h and 6 h) to determine the peak in generation of DOX-induced ROS. DOX-induced ROS generation started from 0.5 h, peaked at 3 h and declined after 3 h time point ( Fig. 2A ). Neferine pre-treatment significantly reduced the ROS generated due to DOX-exposure. No significant change was observed in the group which received neferine treatment alone (Fig. 2B ). The same results were confirmed using fluorescent imaging, where DOX-treatment showed higher fluorescent intensity of DCF when compared to control. Neferine pre-treatment followed by DOX-treatment showed a marked reduction in DCF fluorescence when compared to DOX-alone treated group (Fig. 2C ).
Neferine pre-treatment suppressed DOX-induced activation of ERK1/2 and p38
MAPKinases. MAPKinases are known to get activated in response to ROS. H9c2 cells were treated with DOX for various time points (0 h, 1 h, 3 h, 6 h, 12 h and 24 h) and analyzed for the activation of MAPKinases, ERK1/2 and p38. Activation of these proteins was significant in all the time points compared to control. Peak in expression and activation of ERK1/2 was observed at 3 h of DOX-exposure compared to other time points, whereas the peak in activation and expression levels of p38 was observed at 24 h time point of DOX-treatment ( Fig. 2D ). Neferine pre-treatment effectively modulated DOX-induced ERK1/2 and p38 MAPKinase activation, evident with the reduced phosphorylation levels of p-ERK1/2 and p-p38. The results were confirmed by exposing the DOX-treated H9c2 cells to SB203580 (p38 inhibitor), which resulted in a decreased phosphorylation of p38 compared to DOX-alone treated group ( Fig. 2E -G).
Neferine pre-treatment reduced intracellular calcium [Ca 2+ ]i accumulation in H9c2 cells. ROS
and H 2 O 2 generated by DOX disturb the function of sarcoplasmic reticulum and alter calcium (Ca 2+ ) homeostasis. Ca 2+ accumulation in the cardiomyocytes plays an important role in the pathogenesis of DOX-induced cardiomyopathy 2 . Measurement of [Ca 2+ ]i levels using Fura 2/AM in H9c2 cells at different time points (0 h, 0.5 h, 1 h, 2 h, 3 h, 4 h, and 5 h) showed a peak in accumulation by 2 h of DOX-exposure significantly different from control ( Fig. 2H ). Whereas pre-treatment with neferine for 24 h markedly reduced the Ca 2+ accumulation inside the H9c2 cells ( Fig. 2I ).
DOX-induced nuclear translocation of NFκB, expression of COX2 and TNF-α was attenuated by neferine treatment.
NFκB is a crucial pro-inflammatory transcriptional factor activated in response to various stimuli including ROS. Activation and nuclear translocation of NFκB p65 may trigger inflammatory response and apoptosis 18 . Expression analysis of NFκB p65 in the nuclear extract revealed a significant increase upon DOX-exposure at various time points. A peak in expression levels of NFκB p65 was found at 3 h of DOX-treatment when compared with other time points of DOX-treatment. Analysis on the downstream regulators of NFκB p65, such as COX2 and TNF-α also showed a time dependent response to DOX-treatment ( Fig. 3A) . Neferine pre-treatment for 24 h followed by DOX-exposure for 3 h reduced the levels of NFκB p65 in the nuclear extract with a subsequent suppression in the expression levels of COX2 and TNF-α upon DOX-treatment. The results were confirmed by exposing the DOX-treated H9c2 cells to QNZ (NFκB p65 inhibitor), which resulted in inhibition of NFκB p65 nuclear translocation and suppression of the downstream targets, COX2 and TNF-α expressions compared to DOX-alone treated group (Fig. 3B ,C).
Neferine pre-treatment improves mitochondrial membrane potential in DOX-treated cells. Maintenance of mitochondrial membrane potential (ΔΨm) is vital for cell survival. Dissipation in
ΔΨm may lead to apoptosis 18 . DOX-exposure to H9c2 cells resulted in a significant loss of ΔΨm compared to control. CCCP, a mitochondrial uncoupler also caused ΔΨm loss in the cardiomyoblast. A significant increase in ΔΨm was observed in cells which received neferine pre-treatment followed by DOX-exposure, compared to DOX-alone treated cells. Neferine alone pre-treated cells showed no significant effect on ΔΨm (Fig. 4A,B ).
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Neferine treatment limits increase in sub G1 apoptosis induced by DOX-treatment in H9c2 cells. DOX (1 µM) treatment lead to a significant increase in sub G1 apoptosis (8.3%) compared to control cells (0.5%). Whereas H9c2 cells pre-treated with neferine significantly reduced the DOX-induced sub G1 apoptosis . In order to confirm the above results, expression levels of cell cycle protein, cyclin D1 was measured using western blot analysis. DOX-reduced the expression levels of cyclin D1 when compared to control. Neferine pre-treatment significantly increased the expression levels of cyclin D1 in H9c2 cells compared to DOX-alone treated cells ( Fig. 5D ,E).
Neferine significantly reduces DOX-induced DNA breaks, intrinsic apoptosis and morphological changes in H9c2 cardiomyoblast cells. Results of TUNEL assay confirmed the apoptotic event in
DOX-treated H9c2 cells, which is evident from the formation of DNA breaks and apoptotic body formation ( Fig. 6A,B ) with a significantly decreased expression of the anti-apoptotic protein, Bcl-2 and phosphorylated Bad. This happened with simultaneous induction of cytochrome c release, increased Bax expression, activated caspase-3, caspase-9 and PARP cleavage significantly upon DOX-exposure to H9c2 cells, compared to control 
Discussion
ROS generated via NADPH oxidase system is a major contributor to the cardiac dysfunction or cardiomyopathy induced by DOX 6 . NOX2 and NOX4 isoforms of NOX family, associated with p22phox are predominantly expressed in cardiomyocytes 21 . NOX2 also referred to as gp91phox, present in sarcolemma forms a transmembrane heterodimer complex by post-translational modification with other regulatory subunits (p47phox, p67phox, p40phox and Rac1) and p22phox upon activation by agonist. Active NOX2-p22phox complex plays a crucial role in cardiac redox signaling 22 . NOX2 plays a central role in heart failure by activation of MAPKinases and NFκB through stimuli by mechanical stress, angiotensin II and endothelin-1 in myocardium 21 . Pharmacological inhibition of NOX system by apocyanin or genetic deletions of NOX2 or p47phox subunit have shown to possess cardioprotective effect by inhibition of ROS production [23] [24] [25] . Herein we discussed the time dependent expressions of the key components of NADPH oxidase system, ROS generation, MAPKinases phosphorylation and nuclear translocation of NFκB in a sequential manner which finally resulted in myocardial apoptosis upon DOX-exposure and the counteracting effect by neferine pre-treatment.
Results of our present study showed increased expressions of NOX2/gp91phox, p47phox and p22phox in a time dependent manner in H9c2 cardiomyoblast as the primary event triggered in response to DOX. Brandt, et al. 26 observed the activation of NOX2, p22phox in addition to Rac1 subunit expression in membrane fractions of cultured cardiomyocytes as well as in alcoholic cardiomyopathy animal models 26 . The induction of NOX subunits may be due to the metabolic activation of DOX by NOX system of H9c2 cells. Cheng et al. have reported the impairment in ubiquitination and proteosomal degradation of NOX subunits such as gp91phox, p47phox and p22phox in DOX-mediated cardiotoxicity 27 . The ROS quenching efficacy of neferine by its antioxidant property might have suppressed the induction in the expression levels of these subunits.
Alterations in calcium transport inside the myocardial cells have a close association with myocardial remodeling. Excess Ca 2+ accumulation by calcium transporters might lead to decreased cardiac systolic potential and increased frequency of sudden cardiac death 28 . Intracellular Ca 2+ accumulation peaked at 2 hr after exposure to DOX in our study. DOX-mediated Ca 2+ overload in cardiac cells results in mitochondrial calcium overload and alterations of energy metabolism which in turn promote ROS generation 29 . ROS-associated opening of ryanodine receptor (RyR) might trigger the release of Ca 2+ ions from sarcoplasmic reticulum in the myocardium 30 . NOX2 derived ROS sensitize RyR and enhance Ca 2+ release in cardiomyocytes. Also, the expression levels/open-state probability of L-type calcium channels may be modulated by angiotensisn-II/endothelin I via NOX2 21 . Elevated Ca 2+ concentration in myocardium have been shown to trigger caspase-12, which results in cardiac dysfunction 31 . Neferine prolonged action potential duration by blocking L-type calcium channel in in vitro and in vivo arrhythmic models 29 . Neferine inhibits [Ca 2+ ]i induced by ADP and prevents the internal release of Ca 2+ 32 . Reduction in the levels of DOX-mediated ROS by neferine was evident from our study. Preventing ROS mediated RyR opening might be a crucial factor in reducing DOX-induced cardiotoxicity.
ROS generation in response to DOX-initiated at 30 min and peaked at 3 h and lead to dissipation of ΔΨm in the present study. Several reports have shown that NOX and mitochondrial electron transport chain are the major source for ROS generation in cardiac cells 33, 34 . NADPH oxidase activated by angiotensin II triggers O 2
•− production in mitochondria, which confirms the cross talk between NADPH oxidase system and mitochondrial ROS 35 . Elevation in the total cellular ROS upon DOX-treatment in the present study might have also been from the crosstalk between mitochondrial ROS and NADPH oxidase system in H9c2 cardiomyoblasts. Activation of NADPH oxidase produces superoxide via angiotensin II receptor type 1, leads to activation of kinases (protein kinase C (PKC) and Src-kinase). PKCε, a redox sensitive kinase in mitochondria was activated by superoxide produced by NADPH oxidase 35 . Hyper generation of ROS initiates the opening of mitochondrial permeability transition pores (MPTP) and release free radicals across inner and outer mitochondrial membrane 36 , which results in decreased mitochondrial membrane potential. Persistence of MPTP opening for a longer duration causes swelling of mitochondria and myocardial damage 37 . Reduction in the levels of ROS generation and dissipation of ΔΨm might be due to the free radical scavenging and Ca 2+ channel blocking activity of neferine. Similar results were reported earlier by Dong et al. as well as Qian et al. 32, 38 .
ROS acts as a stimuli and modulates several signaling kinases including MAPKinases, PI3K/Akt, protein kinase C and Wnt/β-catenin 39 . NOX mediated ROS hypergeneration in myocardial cells activates MAPKinases such as ERK1/2 and JNK, which may lead to TNF-α production and myocardial dysfunction 40 . DOX activates JNK/ERK through NADPH oxidase dependent mechanism while p38 expression is mediated through NADPH oxidase independent mechanism in cardiomyocytes 41 . Time course elucidation on the molecular downstream regulators of ROS generated by DOX showed a time dependent activation of ERK1/2 and p38 MAPKinases. Neferine pre-treatment reduced the activation by phosphorylation of ERK1/2 and p38 kinases caused by DOX-exposure. Neferine exhibited anti-fibrogenic effect by inhibiting the activation of ERK1/2 and p38 MAPKinases signaling in cardiac fibroblasts 42 .
Redox-sensitive activation of signaling kinases like ERK, p38 and JNK via NOX dependent or independent manner leads to the induction of transcription factors like NFκB, HIF1-α (hypoxia inducible factor-1a) and Nrf2, which may prevent apoptosis or cardiac fibrosis in causing myocardial damage 43 . NFκB, a pro-inflammatory transcription factor plays a crucial role in deciding the cell fate. Activation and nuclear translocation of NFκB could trigger apoptosis and inflammation in heart 44 . Under normal physiological conditions, NFκB remains in an inactive form in cytoplasm by association with IκB. Upon stimuli by ROS or other kinase signaling, IκB dissociates and undergo ubiquitination and proteasomal degradation, then frees NFκB to translocate into nucleus which acts as a transcription activator for the genes involved in inflammation 45 . COX2, one of downstream regulator of NFκB, was known to be involved in inflammation. Preventing inflammatory responses in heart using interleukin converting enzyme inhibitors and anti-TNF-α monoclonal antibody improves cardiac function against diabetes induced cardiomyopathy 46 . DOX-induced inflammatory response occurred through NFκB pathway was confirmed by the use of NFκB specific inhibitor in the present study. The activation of pro-inflammatory genes NFκB, COX2 and TNF-α happened in a time dependent manner starting from 1 hr to 24 hr. H9c2 cells exposed to DOX for 3 h translocated NFκB to the nucleus and subsequently stimulated the expressions of COX2 and TNF-α. Neferine influenced the activation of NFκB pathway by reduced activation and translocation of NFκB to the nucleus during DOX-treatment. Neferine by virtue of its antioxidant property could have reduced the ROS/MAP kinase mediated nuclear translocation of NFκB, modulating the expression of its downstream regulators COX2 and TNF-α. Nuclear translocation of NFκB and up-regulation of COX2 and TNF-α was prevented by NFκB inhibitor QNZ in presence of DOX. Reduction in the nuclear translocation of NFκB by neferine pre-treatment was reported in our previous studies against hypoxic challenge in muscle cells 18 . Anti-amnesic effects of neferine by antioxidant and anti-inflammatory properties along with the inhibition of ChEs and BACE1 were reported 15 .
Here we confirmed the anti-inflammatory role of neferine by modulating the redox sensitive activation of NFκB pathway against DOX-exposure.
NADPH oxidase mediated activation of MAPKinases may modulate variety of biological functions including gene expression, cell cycle control, cell survival and apoptosis. NADPH oxidase may also promote cell survival signaling pathway as cellular adaptation to stress or it may promote apoptosis in irreversibly damaged cells 47 . Apoptosis in cardiomyocytes reduced the myocardial cell population and leads to myocardial remodeling 48 . Increasing evidences demonstrate that, sustained myocardial apoptosis might lead to severe loss in myocardial function and heart failure 2, 48, 49 . Apoptotic cell death occurs during different pathological or physiological stimuli are controlled by a set of signaling proteins. Mitochondrial dependent intrinsic apoptosis was the main cause for myocardial loss and cardiac dysfunction in DOX-induced cardiotoxicity. Pro-apoptotic protein Bax, cytochrome c, caspase-9 and caspase-3 are up regulated during DOX-exposure, promoting myocardial apoptosis 50 which is in corroboration with our present results with a significant down-regulation on the anti-apoptotic protein Bcl-2 along with decreased p-Bad levels. Also, DOX-treatment lead to a significantly increased % of sub G1 population by down regulating the cyclin D1, the central regulator of cell cycle and caused double strand DNA breaks, suggesting the key role of NADPH oxidase in DOX-mediated intrinsic pathway of apoptosis in H9c2 cardiomyoblasts. Activation of mitochondrial pathway of apoptosis might be due to the accumulation of [Ca 2+ ]i and dissipation of ΔΨm upon DOX-exposure. DOX-induced oxidative stress and cardiac apoptosis ScienTific RePORtS | 7: 12283 | DOI:10.1038/s41598-017-12060-9 through down-regulation of PI3K/Akt and activation of p38/JNK were suppressed by taurine treatment in rats 31 . Inhibition of NOX system by DPI/apocyanin reduced DOX-induced ROS production, caspase-3 activity and sub-G1 cell population 51 . Neferine with its anti-apoptotic property 18, 52 inhibits the cardiomyoblast apoptosis during DOX-exposure. The anti-apoptotic property of neferine may be attributed to the suppression of oxidative stress by its antioxidant nature and by the enhancement of endogenous enzymic antioxidant activity.
Changes in the microstructures of myocytes lead to altered myocardial function and myocardial loss. H9c2 cells displaying normal morphological architecture with elongated spindle shape helps for the vital electrophysiological function of myocardium 53 . Morphological alterations such as cell shrinkage, rounding up, membrane blebbing and translocation of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane are characteristic features of the cells undergoing apoptosis 54 which ratifies our present results upon DOX-exposure. Neferine attenuated these structural abnormalities and maintained near normal cellular functions. Protection of the histoarchitecture of myocardium by neferine pre-treatment was shown against isoproterenol induced cardiotoxicity 19 .
Activation of NADPH oxidase and ROS hypergeneration disrupts the redox balance of H9c2 cardiomyoblasts, results in the activation of stress kinases (ERK1/2, p38) and the pro-inflammatory cytokines, NFκB, COX2 and TNF-α which finally leads to apoptotic cell death upon DOX-exposure. Neferine inhibited NFκB activation and decreased TNF-α, IL-6 and endothelin-1expressions in bleomycin induced pulmonary fibrosis 55 . Also, neferine attenuated hyperglycemia-induced endothelial cell apoptosis by suppressing ROS/Akt/NFκB signalling 52 . The maintenance in the structural integrity of H9c2 cells by neferine pre-treatment might be due to the antioxidant and anti-inflammatory nature of neferine curbing the converging effects of redox-signaling and activation of apoptotic cascade as an ultimate event in DOX-induced cardiotoxicity. The results of the present report in addition to our previous lab studies 17 suggests the therapeutic application of neferine with its differential role in normal and cancer cell line for the combinatorial therapy in cancer treatment with DOX, minimizing the major cardiac side effects. Figure 7 depicts the mechanistic action of neferine on DOX-mediated toxicity in H9c2 cells.
Materials and Methods
Chemicals, reagents and antibodies. Doxorubicin India). Primary monoclonal antibodies for p22phox (sc-20781), p47phox (sc-14015), gp91phox/Nox2 (sc-5827), p-ERK1/2 (sc-7383), p-p38 (sc-7973), NfκB (sc-109), COX2 (sc-1745), TNF-α (sc-1350), Bcl-2 (sc-7382), Bax (sc-526), p-Bad (sc-101641), cytochrome C (sc-13560), caspase-9 (sc-8355), β-actin (sc-47778), α-tubulin (sc-5286), cyclin D1 (sc-246), GAPDH (sc-25778), HDAC1 (sc-7872) and HRP conjugated secondary antibodies raised against mouse, rabbit and goat were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody against caspase-3 (#9665 s) was purchased from Cell Signalling Technology (Danver, MA 01923, USA).
Cell culture. Rat cardiomyoblast cells, H9c2 was purchased from National Centre for Cell Science (NCCS), Pune, India. Cells were cultured in DMEM with 10% FBS containing antibiotics (penicillin and streptomycin) in 75 cm 2 flask. Cell culture flask was maintained at 37 °C in a humidified CO 2 incubator (Nuaire make) with 5% CO 2 supply. Cells were sub-cultured at 80% confluency and media was changed once in two days. All the experiments were performed within 20-40 passages in order to confirm cell population, uniformity and reproducibility.
Cell viability determination by MTT assay. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to determine the cell viability 56 . H9c2 cells were seeded in 96 well plates with cell population of 1 × 10 4 cells/well and allowed for attachment overnight at 37 °C in CO 2 incubator. Neferine dissolved in 50% ethanol (v/v) (final working concentration not exceeding 0.01%) and DOX dissolved in deionized water were used. H9c2 cells were treated with neferine (1, 2 ROS estimation. ROS generation in the H9c2 cells were quantified using DCF-DA fluorescent probe according to Lebel, et al. 57 . 1 × 10 5 cells were seeded in 24 well plates and allowed for attachment overnight. Cells were incubated with 10 µM of DCF-DA for 30 min at 37 °C and exposed to DOX for various time points (0.5 h, 1 h, 2 h, 3 h, 4 h, 5 h and 6 h) for time course experiment. In neferine pre-treatment, the cells were exposed to neferine for 24 h followed by DOX for the peak ROS accumulation. At the end of treatment period, cells were harvested, washed with PBS and lysed using Triton X-100. Finally cells were suspended in PBS and fluorescent intensity was measured at Ex/Em, 480/520 nm using Synergy H1 Multi-Mode Reader (BioTek, Winooski, VT, USA). The accumulation of ROS in H9c2 cells were also analyzed visually by using fluorescence microscope (Olympus, Japan) with the Ex/Em of DCF.
Measurement of intracellular calcium [Ca 2+
]i. Intracellular calcium in the H9c2 cells was estimated as described earlier 58 . 1 × 10 5 cells were cultured in 24 well plates and treated with DOX for various time points (0.5 h, 1 h, 2 h, 3 h, 4 h, 5 h and 6 h) to determine the peak accumulation of calcium. In neferine pre-treatment, the cells were exposed to neferine for 24 h followed by DOX at the peak ROS accumulation. At the end of treatment period, cells were washed with buffer A twice for 5 min (5 mM KCl, 2 mM CaCl 2 , 0.5 mM KH 2 PO 4 , 137 mM NaCl, 4 mM NaHCO 3 , and 0.2 mM Na 2 HPO 4 ). The cells were incubated with 4 µM of Fura 2/AM for 45 min and fluorescent intensity of the dye was measured at Ex/Em, 340-380/500 nm in Synergy H1 Multi-Mode Reader (BioTek, Winooski, VT, USA).
Preparation of protein extract and immunoblotting. For analyzing NFκB expression, nuclear extracts
were used. NE-PER ™ Nuclear and Cytoplasmic Extraction Reagents (Thermo Fisher Scientific Inc.) was used to separate the nuclear and cytoplasmic proteins according to manufacturer's instruction. For total protein extraction, CelLytic ™ (Sigma-Aldrich) lysis buffer was used. Bradford method was used to quantify the extracted protein. Equal amount of protein was separated in 12% gel using SDS-PAGE unit (Bio-Rad Laboratories, Hercules, CA, USA) at 100 V for 2 h. Separated proteins from the gel were blotted to activated PVDF membrane using semi-dry transfer unit (Hoefer Inc., Holliston, MA, USA) at 90 V for 1.5 h. Blots were blocked using 5% non-fat milk powder in TBST for 1 h at room temperature. Then the blots were washed with TBST thrice for 5 min each. After that, blots were incubated with specific primary antibody at 4 °C for overnight. Again blots were washed with TBST thrice for 5 min each and incubated with corresponding HRP-conjugated secondary antibody for 1 h at room temperature. Finally the blots were visualized using ECL substrate and images of the blots were analyzed densitometrically using ImageJ software.
Measurement of mitochondrial membrane potential (ΔΨm). Mitochondrial membrane potential
(ΔΨm) in different treatment group was estimated using DiOC6 59 . After treatment period, cells were washed with PBS and incubated with 50 nM of DiOC6 for 30 min at 37 °C. CCCP (50 µM) was used as a positive control for inducing mitochondrial depolarization. Cells were washed with PBS once, resuspended in PBS and fluorescent intensity of DiOC6 measured at Ex/Em, 488/500 nm using Synergy H1 Multi-Mode Reader (BioTek, Winooski, VT, USA). The intact and depolarized mitochondria of H9c2 cells were also analyzed visually by JC-1 staining as per manufacturer's protocol using EVOS fluorescence microscope (Life Technologies, USA) with Ex/ Em, 585/590 nm for normal mitochondria and Ex/Em, 514/529 nm for unhealthy mitochondria.
Cell cycle analysis. 1 × 10 6 cells were seeded in 6 well plates and treated with appropriate dose of neferine and DOX. At the end of treatment period, the cells were harvested, washed with PBS and fixed in 70% ethanol at 4 °C for overnight. Ethanol was removed, cells were washed using PBS and suspended in 500 µl of propidium
